Cardio Diagnostics Holdings Inc. Warrant 2022-25.10.27 on Cardio Dgns HldCardio Diagnostics Holdings Inc. Warrant 2022-25.10.27 on Cardio Dgns HldCardio Diagnostics Holdings Inc. Warrant 2022-25.10.27 on Cardio Dgns Hld

Cardio Diagnostics Holdings Inc. Warrant 2022-25.10.27 on Cardio Dgns Hld

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪7.18 M‬USD
−4.6633USD
‪−8.38 M‬USD
‪34.89 K‬USD
‪1.64 M‬
Beta (1Y)
2.49

About Cardio Diagnostics Holdings Inc.


CEO
Meeshanthini V. Dogan
Website
Headquarters
Chicago
Founded
2017
ISIN
US14159C1119
FIGI
BBG013P15KL9
Cardio Diagnostics Holdings, Inc. engages in the provision of medical diagnostic testing services. It also develops and commercializes a series of products for major types of cardiovascular disease and associated co-morbidities including coronary heart disease (CHD), stroke, heart failure, and diabetes. The company was founded in 2007, and is headquartered in Chicago, IL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.